Anti-N-METHYL-D-aspartate receptor encephalitis, recurrent course
- 13 December 2025
- journal article
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 30 (5)
Abstract
Anti-N-methyl-D-aspartate receptor encephalitis (anti-NMDAR-encephalitis) was first described as an immune-mediated disorder of behavior and cognitive functions in patients with ovarian teratoma. Subsequently, it was recognized as a separate type of autoimmune encephalitis with a characteristic clinical picture and the possibility of development in the absence of data on tumor formations. The course can have both monophase and recurrent variants with periods of improvement or stabilization of the condition and subsequent progression of the disease. The article presents a clinical observation of a patient with a relapse of the disease 2 years later. The diagnosis of anti-NMDAR-encephalitis was established based on the presence of antibodies to NMDA receptor epitopes in the patient's cerebrospinal fluid, both at the onset of the disease and during the relapse. According to foreign literature, the incidence of recurrent anti-NMDAR-encephalitis varies from 12% to 24%, depending on the study, which requires additional monitoring of patients with this diagnosis.Keywords
This publication has 31 references indexed in Scilit:
- Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody EncephalitisJAMA Neurology, 2021
- Clinical characteristics and long-term prognosis of relapsing anti-N-methyl-d-aspartate receptor encephalitis: a retrospective, multicenter, self-controlled studyNeurological Sciences, 2020
- Severe relapse of anti-NMDA receptor encephalitis 5 years after initial symptom onseteNeurologicalSci, 2019
- Anti-NMDA Receptor Encephalitis: Clinical Features and Basic Mechanisms2018
- A clinical approach to diagnosis of autoimmune encephalitisThe Lancet Neurology, 2016
- Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective studyThe Lancet Neurology, 2014
- Immunoadsorption and cyclophosphamide in a relapse of an anti-NMDA-receptor-encephalitisJournal of the Neurological Sciences, 2013
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyThe Lancet Neurology, 2013
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisThe Lancet Neurology, 2011
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008